Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
HR (95 % CI) | P value | HR (95 % CI) | P value | |
Age | ||||
<65 | 1 | |||
≥65 | 1.350 (0.706-2.581) | 0.364 | ||
Gender | ||||
Male | 1 | |||
Female | 0.910 (0.503-1.648) | 0.756 | ||
Location | ||||
Right | 1 | 1 | ||
Others | 0.470 (0.259-0.852) | 0.013* | 0.666 (0.335-1.323) | 0.246 |
Tumor size (cm) | ||||
<5 | 1 | |||
≥5 | 1.801 (0.993-3.267) | 0.053 | ||
AJCC stage | ||||
I + II | 1 | 1 | ||
III + IV | 3.106 (1.701-5.671) | <0.001* | 1.335 (0.305-5.842) | 0.701 |
T stage | ||||
T1 + T2 | 1 | |||
T3 + T4 | 1.662 (0.514-5.370) | 0.396 | ||
N stage | ||||
N0 | 1 | 1 | ||
N1 + N2 | 3.106 (1.701-5.671) | <0.001* | 2.129 (0.468-9.686) | 0.328 |
M stage | ||||
M0 | 1 | 1 | ||
M1 | 10.801 (2.448-47.658) | 0.002* | 14.382 (1.059-195.249) | 0.045* |
Differentiation | ||||
Well + Moderate | 1 | |||
Poor | 2.026 (0.627-6.548) | 0.238 | ||
Vascular invasion | ||||
No | 1 | 1 | ||
Yes | 6.188 (2.093-18.295) | <0.001* | 1.190 (0.264-5.366) | 0.821 |
MEP1A | ||||
Low | 1 | 1 | ||
High | 5.977 (2.651-13.478) | <0.001* | 3.643 (0.305-5.842) | 0.007* |
E-cadherin | ||||
Low | 1 | 1 | ||
High | 0.425 (0.215-0.842) | 0.014* | 0.605 (0.252-1.453) | 0.261 |